The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.


Updates from The Motley Fool

Latest updates on GlaxoSmithKline from Fool.com.  The Fool has written over 900 articles on GlaxoSmithKline.
Should GlaxoSmithKline Break Up?

A breakup sounds like a good idea on paper, but the logistics may make this strategy impossible t...



Stock Performance

View Interactive GSK Charts
Sponsored by

Key Data Points

Primary metrics and data points about GlaxoSmithKline.
Current Price: $37.61
Prev Close: $37.94
Open: $37.58
Bid: $37.26
Ask: $37.65
Day's Range: $37.40 - $37.68
52wk Range: $34.83 - $42.36
Volume: 4,221,259
Avg Vol 3,658,534
Market Cap: $92B
P/E (ttm): 21.80
EPS (ttm): $0.00
Div & Yield: $2.01 (5.6%)

Company Rating

What our community thinks about GlaxoSmithKline.
CAPS Rating 4 out of 5
 
1397 Outperform
88 Underperform
CAPS All Stars
 
314 Outperform
19 Underperform

How do you think GlaxoSmithKline will perform against the market?



You pick for GlaxoSmithKline is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for GlaxoSmithKline.

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers